Details of the Drug Combinations

General Information of This Drug (ID: DMW1OKT)

Drug Name

CBT-501 DMW1OKT

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 1	[1]
------------------------------------------------------------------------------------

List of Combinatorial Drugs (CBD) Containing This Drug

1 Clinical Trial Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
CBT-101 + CBT-501	DCAB9GX	CBT-101	Solid tumour/cancer	[1]
------------------------------------------------------------------------------------

References

1	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)